相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。STING agonist promotes CAR T cell trafficking and in breast cancer
Nuo Xu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Prognostic value of peripheral blood natural killer cells in colorectal cancer
Yan-ping Tang et al.
BMC GASTROENTEROLOGY (2020)
Oncolytic Adenovirus Armed with BiTE, Cytokine, and Checkpoint Inhibitor Enables CAR T Cells to Control the Growth of Heterogeneous Tumors
Caroline E. Porter et al.
MOLECULAR THERAPY (2020)
Genomic basis for RNA alterations in cancer
Claudia Calabrese et al.
NATURE (2020)
The Emerging Landscape of Immune Cell Therapies
Evan W. Weber et al.
CELL (2020)
Repression of the Type I Interferon Pathway Underlies MYC- and KRAS-Dependent Evasion of NK and B Cells in Pancreatic Ductal Adenocarcinoma
Nathiya Muthalagu et al.
CANCER DISCOVERY (2020)
Oncolytic virus-derived type I interferon restricts CAR T cell therapy
Laura Evgin et al.
NATURE COMMUNICATIONS (2020)
Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma
Deepak Raj et al.
GUT (2019)
Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy
Anping Li et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Abscopal effect when combining oncolytic adenovirus and checkpoint inhibitor in a humanized NOG mouse model of melanoma
Lukasz Kuryk et al.
JOURNAL OF MEDICAL VIROLOGY (2019)
Phase I Study of Lentiviral-Transduced Chimeric Antigen Receptor-Modified T Cells Recognizing Mesothelin in Advanced Solid Cancers
Andrew R. Haas et al.
MOLECULAR THERAPY (2019)
Optimizing oncolytic virotherapy in cancer treatment
Kevin Harrington et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients
Seon Ah Lim et al.
FRONTIERS IN IMMUNOLOGY (2019)
PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells
Silvia Pesce et al.
FRONTIERS IN IMMUNOLOGY (2019)
Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer
Philipp Metzger et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Tumor Microenvironment Remodeling by Intratumoral Oncolytic Vaccinia Virus Enhances the Efficacy of Immune-Checkpoint Blockade
Hong Jae Chon et al.
CLINICAL CANCER RESEARCH (2019)
NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors
Robin Parihar et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Immunology of Adenoviral Vectors in Cancer Therapy
Amanda Rosewell Shaw et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
A Hitchhiker's guide to humanized mice: new pathways to studying viral infections
Jessica Katy Skelton et al.
IMMUNOLOGY (2018)
Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells
Margherita Norelli et al.
NATURE MEDICINE (2018)
Talimogene laherparepvec: First in class oncolytic virotherapy
Robert M. Conry et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
A Phase II Study of Pelareorep (REOLYSIN®) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma
Devalingam Mahalingam et al.
CANCERS (2018)
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2018)
A fully-virulent retargeted oncolytic HSV armed with IL-12 elicits local immunity and vaccine therapy towards distant tumors
Valerio Leoni et al.
PLOS PATHOGENS (2018)
Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options
Derya Kabacaoglu et al.
FRONTIERS IN IMMUNOLOGY (2018)
Oncolytic Viruses Partner With T-Cell Therapy for Solid Tumor Treatment
Amanda Rosewell Shaw et al.
FRONTIERS IN IMMUNOLOGY (2018)
Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer
Amanda Rosewell Shaw et al.
MOLECULAR THERAPY (2017)
NKG2C+NKG2A- Natural Killer Cells are Associated with a Lower Viral Set Point and may Predict Disease Progression in Individuals with Primary HIV Infection
Meichen Ma et al.
FRONTIERS IN IMMUNOLOGY (2017)
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma A Phase 1 Dose-Escalation Trial
Nabil Ahmed et al.
JAMA ONCOLOGY (2017)
Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy
Stefani Spranger et al.
CANCER CELL (2017)
Armed Oncolytic Adenovirus-Expressing PD-L1 Mini-Body Enhances Antitumor Effects of Chimeric Antigen Receptor T Cells in Solid Tumors
Kiyonori Tanoue et al.
CANCER RESEARCH (2017)
Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic Adenocarcinoma
Anne M. Noonan et al.
MOLECULAR THERAPY (2016)
Fine-tuning the CAR spacer improves T-cell potency
Norihiro Watanabe et al.
ONCOIMMUNOLOGY (2016)
Natural killer cell memory in infection, inflammation and cancer
Adelheid Cerwenka et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Clinical development of talimogene laherparepvec (T-VEC): a modified herpes simplex virus type-1-derived oncolytic immunotherapy
Kevin J. Harrington et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2015)
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
Nabil Ahmed et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Robert H. I. Andtbacka et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases
Michele W. L. Teng et al.
NATURE MEDICINE (2015)
HER2 Gene Amplification and Protein Expression in Pancreatic Ductal Adenocarcinomas
Klaus Aumayr et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2014)
Combinatorial treatment with oncolytic adenovirus and helper-dependent adenovirus augments adenoviral cancer gene therapy
Lisa Farzad et al.
Molecular Therapy-Oncolytics (2014)
Differential Type I Interferon-dependent Transgene Silencing of Helper-dependent Adenoviral vs. Adeno-associated Viral Vectors In Vivo
Masataka Suzuki et al.
MOLECULAR THERAPY (2013)
Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer
J. Harder et al.
BRITISH JOURNAL OF CANCER (2012)
Capsid-Modified Adenoviral Vectors for Improved Muscle-Directed Gene Therapy
Kilian Guse et al.
HUMAN GENE THERAPY (2012)
A New Human DSG2-Transgenic Mouse Model for Studying the Tropism and Pathology of Human Adenoviruses
Hongjie Wang et al.
JOURNAL OF VIROLOGY (2012)
Chemotherapy Induces Intratumoral Expression of Chemokines in Cutaneous Melanoma, Favoring T-cell Infiltration and Tumor Control
Michelle Hong et al.
CANCER RESEARCH (2011)
MyD88-Dependent Silencing of Transgene Expression During the Innate and Adaptive Immune Response to Helper-Dependent Adenovirus
Masataka Suzuki et al.
HUMAN GENE THERAPY (2010)
Large-Scale Production of High-Quality Helper-Dependent Adenoviral Vectors Using Adherent Cells in Cell Factories
Masataka Suzuki et al.
HUMAN GENE THERAPY (2010)
Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
Helena Harlin et al.
CANCER RESEARCH (2009)
Regression of experimental medulloblastoma following transfer of HER2-specific T cells
Nabil Ahmed et al.
CANCER RESEARCH (2007)
A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer
Michael H. Kershaw et al.
CLINICAL CANCER RESEARCH (2006)
Replication properties of human adenovirus in vivo and in cultures of primary cells from different animal species
C Jogler et al.
JOURNAL OF VIROLOGY (2006)
The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells
M Gumá et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
分享论文
